UBP 301 is an antagonist of kainate receptors. UBP 301 is the N3-4-carboxybenzyl substituted analog II of Willardiine, which was found to be equipotent at AMPA and GLUK5-containing kainate receptors i
相关文献及参考
Fletcher, E., et al.: Pharmacol. Ther., 70, 65 (1996),
Bleakman, D., et al.: Neuropharmacology, 37, 1187 (1998),
Chittajallu, R., et al.: Trends Pharmacol. Sci., 20, 26 (1999),